Bio Voyager

Home > Nature Biotechnology Information > Nature Biotechnology News

Nature Biotechnology News

  • University of Tasmania Tuesday, July 19, 2011 @ 5:54AMThe University of Tasmania (UTAS) was founded by an Act of the Tasmanian Parliament in 1890, and today stands as one of the oldest universities in Australia. UTAS is committed to the creation, preservation, communication and application of knowledge, along with achieving excellence in all aspects of education – teaching, research and scholarly activities. Research
  • Nano lab gone astray Tuesday, July 19, 2011 @ 4:53AMIn the midst of sharks, fish and children at the experimental museum Universeum in Gothenburg, researchers from Chalmers are conducting advanced nano research. The aim is to demonstrate exactly how modern laboratory work takes place. Sitting in a glass cage a number of focused young men and women can be seen peering into a microscope.
  • Novel approach for preventing HIV infection Tuesday, July 19, 2011 @ 1:24AMScientists at Osel Inc. and the National Cancer Institute (NCI) have developed a new way to prevent HIV infection by genetically enhancing the ability of naturally occurring vaginal bacteria to block viral transmission.
  • Newly Developed Fluorescent Protein Makes Internal Organs Visible Monday, July 18, 2011 @ 3:21PMResearchers at Albert Einstein College of Medicine of Yeshiva University have developed the first fluorescent protein that enables scientists to clearly "see" the internal organs of living animals without the need for a scalpel or imaging techniques that can have side effects or increase radiation exposure. The new probe could prove to be a breakthrough in whole-body imaging – allowing doctors ...
  • New Way Of Growing Enough Adult Stem Cells For Therapeutic Use With Nanoscale Plastic Monday, July 18, 2011 @ 2:21PMIn what is being described as a stem-cell breakthrough, scientists at the Universities of Glasgow and Southampton, UK, have devised a new way of cultivating enough adult stem cells for therapeutic use, which could accelerate research into stem cell treatments for Parkinson's disease, arthritis, Alzheimer's disease and many other illnesses and conditions. The research has been published in the ...
  • Method could be used to enhance stem cell therapies Monday, July 18, 2011 @ 10:44AMA method for growing adult stem cells for therapeutic use has been developed by researchers at the universities of Glasgow and Southampton.
  • Stem cell expansion method hailed Sunday, July 17, 2011 @ 4:48PMScientists have uncovered a new method for culturing adult stem cells which could help in developing therapy for conditions such as arthritis, Alzheimer's and Parkinson's disease.
  • 'Better way' to grow stem cells Sunday, July 17, 2011 @ 12:04PMScientists from Southampton and Glasgow universities develop a new plastic surface which overcomes the difficulties associated with growing stem cells.
  • Precision gene targeting in stem cells corrects disease-causing mutations Saturday, July 16, 2011 @ 1:21PMUsing two distinct methods, researchers have successfully and consistently manipulated targeted genes in both human embryonic stem cells and induced pluripotent stem cells (adult cells that have been reprogrammed to an embryonic stem cell-like state). In one case, scientists employed proteins known as zinc finger nucleases to change a single base pair in the genome, allowing them either to ...
  • New Anti-Doping Test Looks for Biochemical Changes over Time Friday, July 15, 2011 @ 4:17PMBy Ewen Callaway of Nature magazine Cyclist Borut Bozic drew his hands to his chest with a look of joy, disbelief and exhaustion after defeating some of the world's best sprinters in the Swiss village of Tobel. [More]
  • Biodesix Closes on $20M Series D Round Friday, July 15, 2011 @ 9:44AMNEW YORK (GenomeWeb News) – Biodesix has closed on a $20 million Series D financing round, the company announced yesterday.
  • Research on PDL BioPharma Inc. and Biogen Idec Inc. - Biotechnology Sector Always Interesting and Volatile Friday, July 15, 2011 @ 7:59AMJOHANNESBURG, SOUTH AFRICA--(Marketwire - 07/15/11) - www.stockcall.com/ offers investors comprehensive research on the Biotechnology industry and has completed analytical research on PDL BioPharma Inc. (NASDAQ: PDLI - News ) and Biogen Idec Inc. (NASDAQ: BIIB - News ). Register with us today at www.stockcall.com/ to have free access to these ...
  • InoLife Technologies Acquires STEMTIDE Thursday, July 14, 2011 @ 8:52AMAgreement Provides Manufacturing and Distribution Rights to "Stem Cell" Anti-Aging ProductsRALEIGH, ...
  • InoLife Technologies, Inc. Acquires STEMTIDE, Inc. Thursday, July 14, 2011 @ 8:00AMRALEIGH, N.C. and HOUSTON -- InoLife Technologies, Inc. , a service based healthcare products development, integration and marketing company, announced today its acquisition of all of the outstanding shares of common stock of Stemtide, Inc., .
  • MoneyTV to Air 13 Weeks of Coverage on MMRGlobal Beginning Friday, July 15, 2011 Thursday, July 14, 2011 @ 7:35AMLOS ANGELES, CA--(Marketwire - 07/14/11) - Bob Lorsch, CEO of MMRGlobal, Inc. (OTC.BB: MMRF - News ), will appear on "MoneyTV with Donald Baillargeon" on Friday, July 15th to discuss the opportunity for investors in health IT. MMRGlobal offers a suite of health IT products and services, including the MyMedicalRecords.com Personal Health Record for consumers, healthcare professionals, employers ...
  • Foster Wheeler and SOCAR to Form a New Joint Venture Company in Azerbaijan Thursday, July 14, 2011 @ 7:26AMFoster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has signed a Memorandum of Understanding ...
  • Magic carpet Thursday, July 14, 2011 @ 7:12AMResearchers develop fully recyclable floor covering
  • Vical Announces Scientific Advances for Multiple Programs at DNA Vaccines 2011 Conference Thursday, July 14, 2011 @ 5:30AMSAN DIEGO -- Vical Incorporated announced today a summary of the company's scientific presentations at the DNA Vaccines 2011 conference, .
  • Arabidopsis thaliana helps scientists to solve puzzles in human health Thursday, July 14, 2011 @ 12:29AMA tiny plant called Arabidopsis thaliana just helped scientists unearth new clues about the daily cycles of many organisms, including humans. This is the latest in a long line of research, much of it supported by the National Institutes of Health, that uses plants to solve puzzles in human health.
  • GMO 101: What you need to know about genetically modified foods Wednesday, July 13, 2011 @ 11:21PM(ARA) - If you've ever eaten canned soup, sipped soda or chewed sugarless gum, chances are you've eaten something that's been genetically modified, also called GMO. Even when you cook at home, GMOs are in the ingredients we use. It's hard to believe, but GMOs are in almost everything we eat - according to the Grocery Manufacturer's Association, 80 percent of our processed food is genetically ...
  • Free Seminar Will Highlight Oil Spill Wednesday, July 13, 2011 @ 11:16AMDr. Terry Hazen, a leading authority on oil biodegradation will deliver a free seminar at 7 p.m. on Wednesday, July 27, in the Caylor Auditorium at The University of Southern Mississippi Gulf Coast Research Laboratory (GCRL). - A Press Release from the University of Southern Mississippi
  • Innovative system for producing carpets Tuesday, July 12, 2011 @ 10:24AMIn Europe 700 million square meters of carpets are produced each year, and in the United States the volume is ten times higher. Researchers have now developed an enzyme-based biological technology that paves the way for manufacturing carpets that are much lighter, sustainable, biodegradable, and 100% recyclable. A wool carpet manufactured using this innovative system is a completely natural and ...
  • Foster Wheeler Awarded Contract For A Delayed Coker Heater In Argentina Tuesday, July 12, 2011 @ 6:55AMFoster Wheeler AG announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by YPF S.A. for the delayed coker heater for the new delayed coking unit at YPF's Complejo Industrial La Plata in Argentina.
  • Kenya: The Shocking Reality About GMOs Tuesday, July 12, 2011 @ 12:47AMThe spectre of people developing new and strange allergies, indigenous seeds losing their genetic codes and disappearing altogether, farmers making bumper harvests -- or no harvests at all -- is in the air.
  • 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO Monday, July 11, 2011 @ 7:00PMSHENYANG, China , July 11, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX - News ) ("3SBio" or "the Company"), a leading China -based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the Chinese State Food and Drug Administration ("SFDA") has approved its 36,000 IU dosage formulation of EPIAO for ...
  • Kenya Set to Green-Light Genetically Modified Crops Monday, July 11, 2011 @ 5:17PMBy Natasha Gilbert of Nature magazine Kenya is expected to become the fourth African country to allow the commercial production of transgenic crops. The country's National Biosafety Authority is due to publish long-awaited regulations governing the cultivation of genetically modified (GM) crops in open fields for research and commercial purposes. [More]
  • States Now Fund Most Embryonic Stem Cell Research in U.S. Monday, July 11, 2011 @ 4:54PMTUESDAY, Dec. 14 (HealthDay News) -- Most of the human embryonic stem cell research conducted in the United States is funded by states, not the federal government, a new study reveals.
  • Video May Help Predict Which Embryos Will Survive IVF Monday, July 11, 2011 @ 3:30PMMONDAY, Oct. 4 (HealthDay News) -- Using time-lapsed video to watch fertilized eggs grow may offer clues about which embryos have the best chances of resulting in pregnancy when using in vitro fertilization, Stanford researchers report.
  • Will those genetically modified soy beans make you sick? Monday, July 11, 2011 @ 2:11PMScience-ish looks at the research into GMOs
  • Life Sciences: The Rodney Dangerfield of Venture Capital Monday, July 11, 2011 @ 1:12PMNote to Readers: This blog post was co-written by Bruce Booth and Bijan Salehizadeh, who co-authored an article in the July 2011 issue of Nature Biotechnology, detailing the differences in returns between Life Sciences and Tech investing.
  • Lunenfeld Researchers Using SRM-MS to Quantify Kinetics of Protein-Protein Interactions Friday, July 8, 2011 @ 2:30PMA research team led by scientists at the Samuel Lunenfeld Research Institute of Toronto's Mount Sinai Hospital has devised a technique combining affinity purification and selective-reaction monitoring mass spectrometry to quantify the dynamics of protein-protein interactions.
  • The Anthropocene Debate - Do Humans Deserve Their Own Geological Era? Friday, July 8, 2011 @ 2:27PMWith climate change, concrete deserts and agriculture, human beings have fundamentally altered the face of the Earth. But have we really ushered in a new geological era, the so-called Anthropocene?
  • Merck Serono announces recipients of second Grant for Fertility Innovation Friday, July 8, 2011 @ 2:48AMMerck Serono, a division of Merck KGaA, Darmstadt, Germany, today announces the recipients of its second Grant for Fertility Innovation.
  • Undergrads spend summer as researchers Thursday, July 7, 2011 @ 11:44AMTwo dozen undergraduates at the University of California, San Diego have begun their summer of being full-time researchers with faculty advisors across campus.
  • Biovests Personalized Lymphoma Vaccine Featured in Cancer Research Institute/MD Becker Partners Cancer Immunotherapy ... Thursday, July 7, 2011 @ 9:55AMBiovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, ...
  • Auxogyn Initiates Clinical Study for Non-Invasive Embryo Assessment Technology Used During In Vitro Fertilization Monday, July 4, 2011 @ 2:38AMMENLO PARK, Calif., June 4, 2011 /PRNewswire/ -- Auxogyn, Inc., a privately held medical technology company focused on women's reproductive health, today announced that it initiated a multi-center clinical study to validate its e arly e mbryo v iability a ssessment (Eeva(TM)) System for use in in vitro fertilization (IVF). The Eeva System is designed to be used by embryologists to help identify ...
  • Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as ... Sunday, July 3, 2011 @ 12:11PMBiogen Idec (NASDAQ: BIIB), a leader in the research and development of treatments for people with multiple sclerosis (MS), today announced results ...
  • Universities must play vital role in development: Governor Friday, July 1, 2011 @ 6:51PMPanaji, Jun 30 (UNI) Stating that the Universities in India are creators and disseminators of knowledge playing a very important role in development of human resources in a large number of disciplines, Goa Governor Dr S S Sidhu today stressed that they are expected to inculcate and develop higher values of nationalism, integrity and ethics among students in order to strengthen the very ...
  • AltheaDx Adds Next-Gen Sequencing Services for Biomarker Discovery, Clinical Trial Testing Friday, July 1, 2011 @ 12:14AMAltheaDx has added next-generation sequencing services to its clinical molecular pathology laboratory for applications in cancer biomarker discovery and clinical trial testing, the company said this week.
  • Centiva Proposes to Raise New Capital, to Reorganize and to Distribute Assets to Shareholders Thursday, June 30, 2011 @ 12:17PMTORONTO, ONTARIO--(Marketwire - June 30, 2011) - Centiva Capital Inc. (TSX VENTURE:CVC) (" Centiva " or the " Company ") is pleased to announce that it intends to proceed with a private placement of common shares for gross proceeds of a minimum of $3,000,000 and a maximum of $3,500,000 (the " Financing ").
  • Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics Thursday, June 30, 2011 @ 9:26AMCAMBRIDGE, Mass. and MUNICH, June 30, 2011 /PRNewswire/ -- Metamark Genetics, a privately-held oncology molecular diagnostic company, and Definiens, the leading Health Image Intelligence(TM) company, today announced a development and commercialization partnership in which Metamark will combine its proprietary multiplex protein detection platform with image analysis technology developed jointly ...
  • Ottawa Watch Tuesday, June 28, 2011 @ 11:26AMHuman and animal health. The Life Science Association of Manitoba (LSAM) and Ag-West Bio Inc., the biotechnology sector membership organizations in both provinces, applaud the nature of the LOI.
  • Alnylam Presents New Data from ALN-TTR Program at Peripheral Nerve Society Meeting Tuesday, June 28, 2011 @ 7:23AMCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is presenting new data from its ALN-TTR program at the 2011 Peripheral Nerve Society Meeting being held in Potomac, Maryland. The company is reporting results from a natural history study which was designed to measure blood levels of wild-type and mutant ...
  • Vical Provides Allovectin(R) and Herpes Simplex Vaccine Updates at BIO International Convention Tuesday, June 28, 2011 @ 5:30AMWASHINGTON -- Vical Incorporated announced today that the company is presenting updates on its Phase 3 Allovectin immunotherapeutic for metastatic melanoma and its preclinical herpes simplex type 2 vaccine at the BIO International Convention .
  • Living Antibiotic Effective Against Salmonella Monday, June 27, 2011 @ 10:09PMScientists have tested a predatory bacterium – Bdellovibrio – against Salmonella in the guts of live chickens. They found that it significantly reduced the numbers of Salmonella bacteria and, importantly, showed that Bdellovibrio are safe when ingested. The research was funded by the Biotechnology and Biological Sciences Research Council, carried out by Professor Liz Sockett's team at The ...
  • SIGA to Sell 1.7 Million Courses of ST-246(R) to National Stockpile Under Modified BARDA Contract Monday, June 27, 2011 @ 6:00PMNEW YORK -- SIGA Technologies, Inc. announced today that the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services has advised that the protest filed against the contract it awarded to SIGA for the sale of SIGA's smallpox antiviral ST-246 has been withdrawn following execution of a contract modification by BARDA.
  • Resverlogix Announces New Data on Autoimmune Program featured at World Congress of Inflammation Monday, June 27, 2011 @ 1:08PMTSX Exchange Symbol: RVX CALGARY, June 27, 2011 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today that key scientific data has been presented in a poster presentation highlighting the novel features of RVX-297, at the 10th World Congress on Inflammation, in Paris, France (poster number P-296, June 27 at 1 pm). The presentation is entitled " An Orally ...
  • Engineer To Launch Bacteria Into Space Aboard the Final Mission of Space Shuttle Atlantis Monday, June 27, 2011 @ 12:49PMThere will be some very interesting passengers on the final mission of the NASA Space Shuttle Atlantis scheduled to launch July 8, 2011: thousands of bacteria.
  • Quality Superhero Goes To Washington D.C. Monday, June 27, 2011 @ 12:40PMColumbiaSoft takes message of truth and accuracy in document control to world’s largest gathering of biotechnology firms in Washington D.C.
  • Who Really Needs Life Insurance? Monday, June 27, 2011 @ 10:50AMMany people are convinced that life insurance is for everyone, but for some its a waste of money.